China-based CanSino Biologics, one of the leads in the COVID-19 vaccine race, inked a deal with Pfizer for one of its products. They executed an agreement with the U.S. global pharmaceutical giant in which Pfizer will promote Menhycia, the Chinese company’s meningitis...
Partnership
Category
Sinovac Inks Deal with Brazilian Institute to Prepare for Phase 3 Clinical Trial of COVID-19 Vaccine
China-based COVID-19 vaccine developer Sinovac Biotech Ltd. (NASDAQ: SVA) inked a clinical development collaboration agreement with a Brazilian producer of immunobiological products called Instituto Butantan to advance clinical trials of CoronaVac, Sinovac’s...
Pfizer Deepens Partnership with BioNTech to Develop mRNA-based COVID-19 Vaccine Competing against Moderna
Pfizer, one of the world’s biggest pharmaceutical companies announced a partnership with Mainz, Germany based BioNTech, to co-develop and distribute (excluding China) a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. The company’s...
Harvard & Merck to Collaborate on New Pathways for the Treatment of Cancer
Harvard and Merck will collaborate on research led by Harvard immunologist Arlene Sharpe seeking to identify new pathways for the treatment of cancer. Under the terms of the agreement with Harvard’s Office of Technology Development, Merck will have the option to...
MD Anderson Inks Deal With Nation of Poland on Cutting-Edged Cancer Treatment Technologies
MD Anderson Inks a strategic partnership with Poland memorializing an agreement to share new technologies in cancer treatment. The deal was signed by Polish Minister of Health Lukasz Szumowski and MD Anderson of University of Texas. Polish President Andrzej Duda and...
Columbia University & Investment Firm Deerfield Management Ink $130M Drug Development Deal
Major academic centers such as Columbia University capitalize on opportunity to form drug development partnerships directly private equity Investors such as Deerfield Columbia University will partner with Deerfield Management to form a drug research and development...
Viela Strikes R&D & Commercialization Deal in China with Hansoh Pharmaceutical Group
Sara Gilgore of Washington Business Journal reports that Gaithersburg-based Viela Bio Inc., has secured a $220 million agreement with Hansoh Pharmaceutical Group. The two have come together so that Hansoh can commercialize Viela’s lead candidate in China. Partnership...
PharmaWatch: AstraZeneca Partners with Transgene for Virus-based Immunotherapy Advancements
France-based Transgene (TNG) a biotech venture that designs and develops virus-based immunotherapies against cancers and infectious diseases announced the inking of deal with global UK pharma AstraZeneca. The two have inked a collaborative research, option and...
Reid Health Inks Partnership with Earlham College
Inside Indiana reports that Reid Health has inked a new partnership with Earlham College to expand the health systems’ teaching center growth. New programs derived from the new partnership include student training and hands-on experience to treat chronically ill...
PharmaWatch: Gilead Partners with New AI Rockstar Insitro to Develop NASH Treatments
Gilead Sciences Inc. issued a press release announcing they have structured a strategic collaboration with Insitro to discover and develop NASH therapies. A three year agreement, Gilead will access Insitro’s proprietary platform to simulate disease models for NASH and...
aTyr Pharma & University of Nebraska Medical Center Expand Partnership
TrialSite News reports reprint of aTyr’s announcement of expansion of partnership with University of Nebraska Medical Center. aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on...